Diffusion kurtosis imaging‐derived histogram metrics for prediction of KRAS mutation in rectal adenocarcinoma: Preliminary findings

Background Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies. Purpose To eval...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 50; no. 3; pp. 930 - 939
Main Authors Cui, Yanfen, Cui, Xue'e, Yang, Xiaotang, Zhuo, Zhizheng, Du, Xiaosong, Xin, Lei, Yang, Zhao, Cheng, Xintao
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.09.2019
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1053-1807
1522-2586
1522-2586
DOI10.1002/jmri.26653

Cover

Abstract Background Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies. Purpose To evaluate the potential role of diffusion kurtosis imaging (DKI)‐derived parameters using histogram analysis derived from whole‐tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma. Study Type Retrospective. Subjects In all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution. Sequence DKI was performed with a 3.0 T MRI system using a single‐shot echo‐planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2. Assessment D, K, and apparent diffusion coefficient (ADC) values were measured using whole‐tumor volume histogram analysis and were compared between different KRAS mutations status. Statistical Tests Student's t‐test or Mann–Whitney U‐test, and receiver operating characteristic (ROC) curves were used for statistical analysis. Results All the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K‐related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively. Data Conclusion DKI metrics with whole‐tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy. Level of Evidence: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:930–939.
AbstractList BackgroundAlthough histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies.PurposeTo evaluate the potential role of diffusion kurtosis imaging (DKI)‐derived parameters using histogram analysis derived from whole‐tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma.Study TypeRetrospective.SubjectsIn all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution.SequenceDKI was performed with a 3.0 T MRI system using a single‐shot echo‐planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2.AssessmentD, K, and apparent diffusion coefficient (ADC) values were measured using whole‐tumor volume histogram analysis and were compared between different KRAS mutations status.Statistical TestsStudent's t‐test or Mann–Whitney U‐test, and receiver operating characteristic (ROC) curves were used for statistical analysis.ResultsAll the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K‐related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively.Data ConclusionDKI metrics with whole‐tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy.Level of Evidence: 3Technical Efficacy: Stage 2J. Magn. Reson. Imaging 2019;50:930–939.
Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies.BACKGROUNDAlthough histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies.To evaluate the potential role of diffusion kurtosis imaging (DKI)-derived parameters using histogram analysis derived from whole-tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma.PURPOSETo evaluate the potential role of diffusion kurtosis imaging (DKI)-derived parameters using histogram analysis derived from whole-tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma.Retrospective.STUDY TYPERetrospective.In all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution.SUBJECTSIn all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution.DKI was performed with a 3.0 T MRI system using a single-shot echo-planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2 .SEQUENCEDKI was performed with a 3.0 T MRI system using a single-shot echo-planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2 .D, K, and apparent diffusion coefficient (ADC) values were measured using whole-tumor volume histogram analysis and were compared between different KRAS mutations status.ASSESSMENTD, K, and apparent diffusion coefficient (ADC) values were measured using whole-tumor volume histogram analysis and were compared between different KRAS mutations status.Student's t-test or Mann-Whitney U-test, and receiver operating characteristic (ROC) curves were used for statistical analysis.STATISTICAL TESTSStudent's t-test or Mann-Whitney U-test, and receiver operating characteristic (ROC) curves were used for statistical analysis.All the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K-related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively.RESULTSAll the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K-related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively.DKI metrics with whole-tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy.DATA CONCLUSIONDKI metrics with whole-tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy.3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:930-939.LEVEL OF EVIDENCE3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:930-939.
Background Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies. Purpose To evaluate the potential role of diffusion kurtosis imaging (DKI)‐derived parameters using histogram analysis derived from whole‐tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma. Study Type Retrospective. Subjects In all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution. Sequence DKI was performed with a 3.0 T MRI system using a single‐shot echo‐planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm2. Assessment D, K, and apparent diffusion coefficient (ADC) values were measured using whole‐tumor volume histogram analysis and were compared between different KRAS mutations status. Statistical Tests Student's t‐test or Mann–Whitney U‐test, and receiver operating characteristic (ROC) curves were used for statistical analysis. Results All the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K‐related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K75th showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively. Data Conclusion DKI metrics with whole‐tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy. Level of Evidence: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:930–939.
Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the heterogeneity of the whole tumor to supplement genotype analysis, might be important for personalized treatment strategies. To evaluate the potential role of diffusion kurtosis imaging (DKI)-derived parameters using histogram analysis derived from whole-tumor volumes for prediction of the status of KRAS mutations in patients with rectal adenocarcinoma. Retrospective. In all, 148 consecutive patients with histologically confirmed rectal adenocarcinoma who were treated at our institution. DKI was performed with a 3.0 T MRI system using a single-shot echo-planar imaging sequence with b values of 0, 700, 1400, and 2100 sec/mm . D, K, and apparent diffusion coefficient (ADC) values were measured using whole-tumor volume histogram analysis and were compared between different KRAS mutations status. Student's t-test or Mann-Whitney U-test, and receiver operating characteristic (ROC) curves were used for statistical analysis. All the percentile metrics of ADC and D values were significantly lower in the mutated group than those in the wildtype group (all P < 0.05), except for the minimum value of ADC and D (both P > 0.05), while K-related percentile metrics were higher in the mutated group compared with those in the wildtype group (all P < 0.05). Regarding the comparison of the diagnostic performance of all the histogram metrics, K showed the highest AUC value of 0.871, and the corresponding values for sensitivity, specificity, positive predictive value, and negative predictive value were 81.43%, 78.21%, 77.03%, and 82.43%, respectively. DKI metrics with whole-tumor volume histogram analysis is associated with KRAS mutations, and thus may be useful for predicting the KRAS status of rectal cancers for guiding targeted therapy. 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:930-939.
Author Zhuo, Zhizheng
Cui, Yanfen
Du, Xiaosong
Xin, Lei
Cheng, Xintao
Cui, Xue'e
Yang, Zhao
Yang, Xiaotang
Author_xml – sequence: 1
  givenname: Yanfen
  surname: Cui
  fullname: Cui, Yanfen
  organization: Shanxi Province Cancer Hospital, Shanxi Medical University
– sequence: 2
  givenname: Xue'e
  surname: Cui
  fullname: Cui, Xue'e
  organization: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
– sequence: 3
  givenname: Xiaotang
  orcidid: 0000-0002-2233-1404
  surname: Yang
  fullname: Yang, Xiaotang
  email: yangxt210@126.com
  organization: Shanxi Province Cancer Hospital, Shanxi Medical University
– sequence: 4
  givenname: Zhizheng
  surname: Zhuo
  fullname: Zhuo, Zhizheng
  organization: Philips Healthcare Greater China
– sequence: 5
  givenname: Xiaosong
  surname: Du
  fullname: Du, Xiaosong
  organization: Shanxi Province Cancer Hospital, Shanxi Medical University
– sequence: 6
  givenname: Lei
  surname: Xin
  fullname: Xin, Lei
  organization: Shanxi Province Cancer Hospital, Shanxi Medical University
– sequence: 7
  givenname: Zhao
  surname: Yang
  fullname: Yang, Zhao
  organization: Shanxi Province Cancer Hospital, Shanxi Medical University
– sequence: 8
  givenname: Xintao
  surname: Cheng
  fullname: Cheng, Xintao
  organization: Shanxi Province Cancer Hospital, Shanxi Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30637861$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u1DAUhS1URH9gwwMgS2wQUoodx06GXVWgFIpABdaW41wPd0jsqZ2AZseme56xT1JP024qxMqW9Z1zr8_ZJzs-eCDkKWeHnLHy1WqIeFgqJcUDssdlWRalbNROvjMpCt6wepfsp7RijC0WlXxEdgVTom4U3yOXb9C5KWHw9OcUx5AwURzMEv3y6s_fDiL-go7-wDSGZTQDHWCMaBN1IdJ1hA7tuNUGRz-eH32lwzSamwf0NIIdTU9NBz5YEy36MJjX9EuEHgf0Jm6oQ9_lSekxeehMn-DJ7XlAvr97--34fXH2-eT0-OissELWomgr1grBWM1kK-tF5cqyrqBi0lW1lflzgjvXMiOdAZAZapTksoZOtq0SlRAH5MXsu47hYoI06gGThb43HsKUdMnrhVBl1fCMPr-HrsIUfd5O56kZFIptDZ_dUlM7QKfXMYcXN_ou4AywGbAxpBTBaYtzRGM02GvO9LZDve1Q33SYJS_vSe5c_wnzGf6NPWz-Q-oPn85PZ801i3mueQ
CitedBy_id crossref_primary_10_1002_mp_15361
crossref_primary_10_1007_s00261_022_03782_0
crossref_primary_10_1016_j_artmed_2024_102931
crossref_primary_10_1016_j_ejrad_2021_109869
crossref_primary_10_1016_j_cmpb_2021_106311
crossref_primary_10_1159_000515631
crossref_primary_10_1002_jmri_28237
crossref_primary_10_1007_s12029_022_00909_w
crossref_primary_10_1016_j_ejrad_2021_109963
crossref_primary_10_4143_crt_2019_050
crossref_primary_10_1007_s00261_019_02073_5
crossref_primary_10_1016_j_patol_2020_07_004
crossref_primary_10_3390_cancers13050973
crossref_primary_10_1186_s43055_020_00393_x
crossref_primary_10_1016_j_crad_2021_06_005
crossref_primary_10_1007_s00330_019_06572_3
crossref_primary_10_1007_s10489_020_01658_8
crossref_primary_10_1016_j_crad_2020_06_023
crossref_primary_10_1016_j_ejrad_2022_110245
crossref_primary_10_1007_s00261_024_04523_1
crossref_primary_10_1007_s12094_020_02357_z
crossref_primary_10_1007_s00261_021_03369_1
crossref_primary_10_1016_j_compbiomed_2024_108293
crossref_primary_10_1016_j_acra_2021_11_024
Cites_doi 10.1007/s00330-018-5495-y
10.3174/ajnr.A5794
10.1097/RLU.0000000000000481
10.1016/j.ejca.2015.04.007
10.1002/mrm.20508
10.1200/JCO.2015.63.9674
10.1097/DCR.0b013e31821d37a3
10.1093/annonc/mdu378
10.1136/gutjnl-2015-310912
10.2967/jnumed.113.120485
10.1002/jmri.25137
10.3174/ajnr.A5516
10.1016/j.urolonc.2015.05.005
10.1245/s10434-010-0985-4
10.1148/radiol.2017170515
10.1259/bjr.20160212
10.1016/S1470-2045(11)70097-3
10.1158/1078-0432.CCR-09-2446
10.21873/anticanres.11039
10.2307/2531595
10.1158/1078-0432.CCR-11-1909
10.1007/s00330-017-5094-3
10.1002/jmri.25696
10.1016/j.amjsurg.2010.08.016
10.1200/JCO.2007.12.5906
10.1002/jmri.25572
10.1016/S0140-6736(05)17706-X
10.1007/s00330-018-5329-y
10.1158/1078-0432.CCR-15-0526
10.1007/s00330-016-4529-6
ContentType Journal Article
Copyright 2019 International Society for Magnetic Resonance in Medicine
2019 International Society for Magnetic Resonance in Medicine.
Copyright_xml – notice: 2019 International Society for Magnetic Resonance in Medicine
– notice: 2019 International Society for Magnetic Resonance in Medicine.
DBID AAYXX
CITATION
NPM
7QO
7TK
8FD
FR3
K9.
P64
7X8
DOI 10.1002/jmri.26653
DatabaseName CrossRef
PubMed
Biotechnology Research Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-2586
EndPage 939
ExternalDocumentID 30637861
10_1002_jmri_26653
JMRI26653
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Applied Basic Research Programs of Shanxi Province
  funderid: 201801D121307; 201801D221390
– fundername: the Science and Technology Project of Shanxi Province
  funderid: 20150313007‐5
GroupedDBID ---
-DZ
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HDBZQ
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7QO
7TK
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
K9.
P64
7X8
ID FETCH-LOGICAL-c3573-b40b3300705b5794f2274e405f47c509931ffb0a5faee505b865157ed5bb63433
IEDL.DBID DR2
ISSN 1053-1807
1522-2586
IngestDate Fri Jul 11 11:17:10 EDT 2025
Fri Jul 25 12:23:07 EDT 2025
Thu Apr 03 06:58:00 EDT 2025
Thu Apr 24 22:52:27 EDT 2025
Tue Jul 01 03:56:41 EDT 2025
Wed Jan 22 16:39:15 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords histogram
diffusion kurtosis imaging
mutations
rectal cancer
Language English
License 2019 International Society for Magnetic Resonance in Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3573-b40b3300705b5794f2274e405f47c509931ffb0a5faee505b865157ed5bb63433
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2233-1404
PMID 30637861
PQID 2272173603
PQPubID 1006400
PageCount 10
ParticipantIDs proquest_miscellaneous_2179362481
proquest_journals_2272173603
pubmed_primary_30637861
crossref_citationtrail_10_1002_jmri_26653
crossref_primary_10_1002_jmri_26653
wiley_primary_10_1002_jmri_26653_JMRI26653
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2019
2019-09-00
20190901
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 09
  year: 2019
  text: September 2019
PublicationDecade 2010
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Nashville
PublicationSubtitle JMRI
PublicationTitle Journal of magnetic resonance imaging
PublicationTitleAlternate J Magn Reson Imaging
PublicationYear 2019
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2018; 28
2018; 286
2010; 16
2015; 51
2017; 27
2010; 17
2017; 66
2017; 46
2015; 33
2011; 54
2012; 18
2011; 12
2016; 36
2016; 34
2011; 202
2015; 26
2018; 39
2005; 365
2015; 21
2008; 26
1988; 44
2018
2005; 53
2016
2014; 39
2014; 34
2014; 55
2016; 89
2016; 44
Suh CH (e_1_2_6_20_1) 2018
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_11_1
e_1_2_6_34_1
e_1_2_6_12_1
e_1_2_6_33_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_21_1
Zhu L (e_1_2_6_25_1) 2016
e_1_2_6_9_1
e_1_2_6_8_1
Krikelis D (e_1_2_6_16_1) 2014; 34
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – volume: 12
  start-page: 575
  year: 2011
  end-page: 582
  article-title: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12‐year follow‐up of the multicentre, randomised controlled TME trial
  publication-title: Lancet Oncol
– volume: 89
  start-page: 20160212
  year: 2016
  article-title: (18)F‐FDG PET/CT imaging in rectal cancer: Relationship with the RAS mutational status
  publication-title: Br J Radiol
– volume: 33
  start-page: 337 e315
  year: 2015
  end-page: 324
  article-title: Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer
  publication-title: Urol Oncol
– volume: 53
  start-page: 1432
  year: 2005
  end-page: 1440
  article-title: Diffusional kurtosis imaging: The quantification of non‐Gaussian water diffusion by means of magnetic resonance imaging
  publication-title: Magn Reson Med
– volume: 286
  start-page: 571
  year: 2018
  end-page: 580
  article-title: Assessment of microvascular invasion of hepatocellular carcinoma with diffusion kurtosis imaging
  publication-title: Radiology
– year: 2018
  article-title: Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: A systemic review and meta‐analysis
  publication-title: Eur Radiol
– volume: 46
  start-page: 281
  year: 2017
  end-page: 289
  article-title: Lung adenocarcinoma: Assessment of epidermal growth factor receptor mutation status based on extended models of diffusion‐weighted image
  publication-title: J Magn Reson Imaging
– volume: 46
  start-page: 1499
  year: 2017
  end-page: 1506
  article-title: Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki‐67 expression
  publication-title: J Magn Reson Imaging
– start-page: 160094
  year: 2016
  article-title: Diffusion kurtosis imaging study of rectal adenocarcinoma associated with histopathologic prognostic factors: Preliminary findings
  publication-title: Radiology
– volume: 21
  start-page: 5469
  year: 2015
  end-page: 5479
  article-title: Analysis of KRAS/NRAS mutations in a Phase III study of panitumumab with FOLFIRI compared with FOLFIRI alone as second‐line treatment for metastatic colorectal cancer
  publication-title: Clin Cancer Res
– year: 2018
  article-title: Predicting genotype and survival in glioma using standard clinical MR imaging apparent diffusion coefficient images: A pilot study from the Cancer Genome Atlas
  publication-title: AJNR Am J Neuroradiol
– volume: 16
  start-page: 790
  year: 2010
  end-page: 799
  article-title: Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases
  publication-title: Clin Cancer Res
– volume: 365
  start-page: 153
  year: 2005
  end-page: 165
  article-title: Colorectal cancer
  publication-title: Lancet
– volume: 39
  start-page: 273
  year: 2018
  end-page: 279
  article-title: Diffusion‐weighted imaging of brain metastasis from lung cancer: Correlation of MRI parameters with the histologic type and gene mutation status
  publication-title: AJNR Am J Neuroradiol
– volume: 36
  start-page: 4799
  year: 2016
  end-page: 4804
  article-title: Prediction of KRAS mutation in rectal cancer using MRI
  publication-title: Anticancer Res
– volume: 39
  start-page: 685
  year: 2014
  end-page: 689
  article-title: Correlation between PET/CT parameters and KRAS expression in colorectal cancer
  publication-title: Clin Nucl Med
– volume: 28
  start-page: 3059
  year: 2018
  end-page: 3065
  article-title: Could IVIM and ADC help in predicting the KRAS status in patients with rectal cancer?
  publication-title: Eur Radiol
– volume: 34
  start-page: 179
  year: 2016
  end-page: 185
  article-title: Extended RAS gene mutation testing in metastatic colorectal carcinoma to predict response to anti‐epidermal growth factor receptor monoclonal antibody therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015
  publication-title: J Clin Oncol
– volume: 44
  start-page: 221
  year: 2016
  end-page: 229
  article-title: Correlation of standard diffusion‐weighted imaging and diffusion kurtosis imaging with distant metastases of rectal carcinoma
  publication-title: J Magn Reson Imaging
– volume: 66
  start-page: 683
  year: 2017
  end-page: 691
  article-title: Global patterns and trends in colorectal cancer incidence and mortality
  publication-title: Gut
– volume: 26
  start-page: 374
  year: 2008
  end-page: 379
  article-title: KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
  publication-title: J Clin Oncol
– volume: 27
  start-page: 1848
  year: 2017
  end-page: 1857
  article-title: The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer
  publication-title: Eur Radiol
– volume: 28
  start-page: 1485
  year: 2018
  end-page: 1494
  article-title: Whole‐tumour diffusion kurtosis MR imaging histogram analysis of rectal adenocarcinoma: Correlation with clinical pathologic prognostic factors
  publication-title: Eur Radiol
– volume: 44
  start-page: 837
  year: 1988
  end-page: 845
  article-title: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
  publication-title: Biometrics
– volume: 54
  start-page: 1170
  year: 2011
  end-page: 1178
  article-title: Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer
  publication-title: Dis Colon Rectum
– volume: 34
  start-page: 2571
  year: 2014
  end-page: 2579
  article-title: Lack of association between KRAS mutations and 18F‐FDG PET/CT in Caucasian metastatic colorectal cancer patients
  publication-title: Anticancer Res
– volume: 18
  start-page: 1696
  year: 2012
  end-page: 1703
  article-title: Relationship between 18F‐fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer
  publication-title: Clin Cancer Res
– volume: 55
  start-page: 386
  year: 2014
  end-page: 391
  article-title: Multifunctional imaging signature for V‐KI‐RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations in colorectal cancer
  publication-title: J Nucl Med
– volume: 51
  start-page: 1243
  year: 2015
  end-page: 1252
  article-title: FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer
  publication-title: Eur J Cancer
– volume: 26
  start-page: 13
  year: 2015
  end-page: 21
  article-title: Extended RAS mutations and anti‐EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: A meta‐analysis of randomized, controlled trials
  publication-title: Ann Oncol
– volume: 17
  start-page: 1471
  year: 2010
  end-page: 1474
  article-title: The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM
  publication-title: Ann Surg Oncol
– volume: 202
  start-page: 419
  year: 2011
  end-page: 426
  article-title: Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma
  publication-title: Am J Surg
– year: 2018
  article-title: Diffusion kurtosis imaging in the characterisation of rectal cancer: Utilizing the most repeatable region‐of‐interest strategy for diffusion parameters on a 3T scanner
  publication-title: Eur Radiol
– ident: e_1_2_6_27_1
  doi: 10.1007/s00330-018-5495-y
– ident: e_1_2_6_21_1
  doi: 10.3174/ajnr.A5794
– ident: e_1_2_6_15_1
  doi: 10.1097/RLU.0000000000000481
– ident: e_1_2_6_9_1
  doi: 10.1016/j.ejca.2015.04.007
– ident: e_1_2_6_22_1
  doi: 10.1002/mrm.20508
– ident: e_1_2_6_10_1
  doi: 10.1200/JCO.2015.63.9674
– ident: e_1_2_6_11_1
  doi: 10.1097/DCR.0b013e31821d37a3
– ident: e_1_2_6_7_1
  doi: 10.1093/annonc/mdu378
– ident: e_1_2_6_5_1
  doi: 10.1136/gutjnl-2015-310912
– ident: e_1_2_6_14_1
  doi: 10.2967/jnumed.113.120485
– ident: e_1_2_6_24_1
  doi: 10.1002/jmri.25137
– start-page: 160094
  year: 2016
  ident: e_1_2_6_25_1
  article-title: Diffusion kurtosis imaging study of rectal adenocarcinoma associated with histopathologic prognostic factors: Preliminary findings
  publication-title: Radiology
– ident: e_1_2_6_19_1
  doi: 10.3174/ajnr.A5516
– ident: e_1_2_6_32_1
  doi: 10.1016/j.urolonc.2015.05.005
– year: 2018
  ident: e_1_2_6_20_1
  article-title: Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: A systemic review and meta‐analysis
  publication-title: Eur Radiol
– ident: e_1_2_6_28_1
  doi: 10.1245/s10434-010-0985-4
– ident: e_1_2_6_31_1
  doi: 10.1148/radiol.2017170515
– ident: e_1_2_6_17_1
  doi: 10.1259/bjr.20160212
– ident: e_1_2_6_3_1
  doi: 10.1016/S1470-2045(11)70097-3
– ident: e_1_2_6_12_1
  doi: 10.1158/1078-0432.CCR-09-2446
– ident: e_1_2_6_18_1
  doi: 10.21873/anticanres.11039
– ident: e_1_2_6_29_1
  doi: 10.2307/2531595
– ident: e_1_2_6_13_1
  doi: 10.1158/1078-0432.CCR-11-1909
– ident: e_1_2_6_26_1
  doi: 10.1007/s00330-017-5094-3
– ident: e_1_2_6_30_1
  doi: 10.1002/jmri.25696
– ident: e_1_2_6_4_1
  doi: 10.1016/j.amjsurg.2010.08.016
– ident: e_1_2_6_6_1
  doi: 10.1200/JCO.2007.12.5906
– volume: 34
  start-page: 2571
  year: 2014
  ident: e_1_2_6_16_1
  article-title: Lack of association between KRAS mutations and 18F‐FDG PET/CT in Caucasian metastatic colorectal cancer patients
  publication-title: Anticancer Res
– ident: e_1_2_6_33_1
  doi: 10.1002/jmri.25572
– ident: e_1_2_6_2_1
  doi: 10.1016/S0140-6736(05)17706-X
– ident: e_1_2_6_34_1
  doi: 10.1007/s00330-018-5329-y
– ident: e_1_2_6_8_1
  doi: 10.1158/1078-0432.CCR-15-0526
– ident: e_1_2_6_23_1
  doi: 10.1007/s00330-016-4529-6
SSID ssj0009945
Score 2.4310129
Snippet Background Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display...
Although histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the...
BackgroundAlthough histological examination is the standard method for assessing genetic status, the development of a noninvasive method, which can display the...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 930
SubjectTerms Adenocarcinoma
Colorectal cancer
Diagnostic systems
Diffusion
Diffusion coefficient
diffusion kurtosis imaging
Genotypes
Heterogeneity
histogram
Histograms
K-Ras protein
Kurtosis
Magnetic resonance imaging
Medical imaging
Mutation
mutations
Predictions
rectal cancer
Rectum
Statistical analysis
Statistical tests
Tumors
Title Diffusion kurtosis imaging‐derived histogram metrics for prediction of KRAS mutation in rectal adenocarcinoma: Preliminary findings
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.26653
https://www.ncbi.nlm.nih.gov/pubmed/30637861
https://www.proquest.com/docview/2272173603
https://www.proquest.com/docview/2179362481
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFLYQB8QFylamBWQEl1bKMLHjLIgLYhGLpqoGkLigKM7YVUqToGTSQ09cuPMb-0v6npPJiEWV4BbJThzbb_nsZ3-PkG2hbU_5GNUFvGABIrYtyVWMNK7g0EDFhIme97-5J1fO2bW4niJ747swNT9Eu-GGmmHsNSp4JMudCWnoz7RIuuBeBFJ92txF4vzDwYQ7KghMhmLAD9yy_Z7XcpOyncmrT73RC4j5FLEal3M8T27GP1ufNLntViPZjf8843F8b28-kLkGi9L9WngWyJTKFslMv4m2L5GHw0TrCrfT6G1VjPIyKWmSmrRGf-8fhyC7v9WQGsZiPONFU8zOFZcUcDC9K_AzOOs01_R8sH9B06oO-9Mko2hnoekIrB440wLay9Nol34voBupuSJMTTQ9-1Euk6vjo8uDE6tJ22DFXHjckk5Pco48QkIKUHfNYOWrABhqx4sBnwTc1lr2IqEjpQCASR_TsXtqKKR0ucP5CpnO8kytEuo5jpKBGEoGXjRiLGCu1gAyfRnEjHt2h3wZT18YN5zmmFrjV1izMbMQxzU049ohW23du5rJ49Vaa2MpCBttLkPoAKzcuNuD4s22GPQQgytRpvIK6qClc5njw099rKWnbQaWZdzzXSj5amTgP-2HZ_3BqXn69JbKn8ksILnm8NsamR4VlVoHtDSSG0Yr_gElBhED
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYKlUovPAoUChRX7aVIWTZ2nEdvq7ZoeSyqtiBxi-KsjQIkQcmmh5564c5v5Jcw42SzokVI9BbJThzbM57PnvE3hHwS2vaUj15dwAsWIGLbklzFSOMKBg1UTBjv-eDY7Z86B2firInNwbswNT9Ee-CGmmHWa1RwPJDenbKGXqRF0gH7IvgMeWkcdIiJhlP2qCAwOYoBQXDL9rtey07KdqfvPrRH_4DMh5jVGJ29hTqzamm4CjHW5LJTjWUn_v0Xk-N_92eRzDdwlPZq-VkiL1T2hrwaNA73ZXLzLdG6whM1elkV47xMSpqkJrPR3Z_bEYjvLzWihrQYw7xoigm64pICFKbXBX4GJ57mmh4Oez9pWtWef5pkFJdaaDqChQ_saQHt5Wn0hf4ooB-puSVMjUM9Oy9XyOne95OvfavJ3GDFXHjckk5Xco5UQkIK0HjNYPOrABtqx4sBogTc1lp2I6EjpQCDSR8zsntqJKR0ucP5KpnN8kytEeo5jpKBGEkGhjRiLGCu1oAzfRnEjHv2Ovk8mb8wbmjNMbvGVVgTMrMQxzU047pOPrZ1r2syj0drbU7EIGwUugyhA7B5424Xij-0xaCK6F-JMpVXUAcXO5c5PvzU21p82mZgZ8Y934WSHSMET7QfHgyG--bp3XMqb5O5_sngKDzaPz7cIK8B2DWxcJtkdlxUagvA01i-NypyDyVLFSE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVceD8KBYzgAlK2GzvOA3GpKKs-2KpaqNRLFcWJjUJJsko2HDhx4c5v5Jcw42SzKiAkuEWyE8f2PD577G8AnknjBjqkqC7iBQcRsesooVOicUWHhiombfR8euTvnXgHp_J0DV4t78J0_BDDhhtphrXXpODzzGyvSEM_FnU-QvcixSW47PnoJwkSzVbkUVFkUxQjgBCOG46DgZyUb6_eveiOfsOYFyGr9TmTa3C2_NvuqMn5qF2oUfrlFyLH_-3Odbjag1G200nPDVjT5U3YmPbh9lvwbTc3pqX9NHbe1ouqyRuWFzav0Y-v3zMU3s86Y5aymA55sYLSc6UNQyDM5jV9hqadVYYdznbesaLt4v4sLxkZWmw6QbOH3rTG9qoiecmOa-xGYe8IMxtOLz80t-Fk8ub96z2nz9vgpEIGwlHeWAlBREJSSdR3w3HpqxEZGi9IEaBEwjVGjRNpEq0RgamQ8rEHOpNK-cIT4g6sl1Wp7wELPE-rSGaKoxtNOI-4bwyizFBFKReBuwnPl9MXpz2pOeXW-BR3dMw8pnGN7bhuwtOh7ryj8vhjra2lFMS9OjcxdgCXbsIfY_GToRgVkaIrSamrFuuQqfO5F-JP3e2kZ2gG12UiCH0seWFl4C_txwfT2b59uv8vlR_DxvHuJH67f3T4AK4gqusPwm3B-qJu9UNETgv1yCrIT942E9A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diffusion+kurtosis+imaging-derived+histogram+metrics+for+prediction+of+KRAS+mutation+in+rectal+adenocarcinoma%3A+Preliminary+findings&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Cui%2C+Yanfen&rft.au=Cui%2C+Xue%27e&rft.au=Yang%2C+Xiaotang&rft.au=Zhuo%2C+Zhizheng&rft.date=2019-09-01&rft.eissn=1522-2586&rft.volume=50&rft.issue=3&rft.spage=930&rft_id=info:doi/10.1002%2Fjmri.26653&rft_id=info%3Apmid%2F30637861&rft.externalDocID=30637861
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon